Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dengue virus adjuvant PV-001-DV

An attenuated strain of dengue virus that was originally developed as a potential preventative vaccine for dengue fever by the US Army as Dengue Virus-1 #45AZ5, with potential immunostimulating activity. Upon administration of dengue virus adjuvant PV-001-DV, the virus may activate both the innate and adaptive immune system.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	dengue virus-1 PV-001-DV PV-001-dengue virus
Code name:	PV 001-DV PV-001-DV PV001-DV

dengue virus adjuvant PV-001-DV

Search NCI's Drug Dictionary